Venoarterial extracorporeal membrane oxygenation (ECMO) can provide temporary cardiopulmonary support for patients in hemodynamic extremis or refractory heart failure until more durable therapies-such as cardiac transplantation or a left ventricular assist device-can be safely implemented. Conventional ECMO cannulation strategies commonly employ the femoral artery and vein, constraining the patients to the supine position for the duration of ECMO support. We have recently adopted a modified cannulation approach to promote patient mobility, rehabilitation, and faster recovery and to mitigate complications associated with femoral arterial cannulation, such as limb ischemia and compartment syndrome. This technique involves cannulation of the subclavian artery and vein. The current case report details our recent experience with this approach in a critically ill patient awaiting cardiac transplantation. E xtracorporeal membrane oxygenation (ECMO) is increasingly utilized in patients with refractory cardiopulmonary disease (1). For patients with refractory heart failure, venoarterial ECMO can provide temporary hemodynamic stabilization as a bridge to more durable therapies. In most instances, venoarterial ECMO is achieved via femoral cannulation, rendering patients supine for the entire duration of support and susceptible to limb ischemia associated with femoral arterial cannulation. We previously reported good outcomes with subclavian arterial cannulation to avoid these complications (2). We recently modifi ed this strategy to concomitant arterial and venous subclavian cannulation to enable ambulation and to promote potentially faster recovery. Here we report a recent patient supported with ambulatory subclavian venoarterial ECMO who was successfully bridged to left ventricular assist device (LVAD) implantation and is currently awaiting cardiac transplantation.
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CASE REPORT
A 59-year-old man with hypertension and sleep apnea was diagnosed with heart failure secondary to nonischemic cardiomyopathy. A recent echocardiogram revealed a left ventricular ejection fraction of 7% and moderate aortic valvular insufficiency. His heart failure symptoms progressed, and he presented to our institution with repeated episodes of ventricular fi brillation, requiring cardiopulmonary resuscitation and defi brilla- tory shocks. Amiodarone infusion and inotropic support with milrinone and dobutamine were started. An intraaortic balloon pump was placed, and he was tentatively listed status 1A for cardiac transplantation. However, despite the level of support and continued escalation of inotropic agents, he failed to achieve adequate hemodynamics or normalizing indices of end-organ perfusion.
Consequently, we proceeded with urgent venoarterial ECMO support in an eff ort to stabilize him before deciding on advanced therapy. To provide the patient with more fl exibility and mobility, we opted for subclavian venoarterial cannulation. Th e left side was chosen because of his right-handedness. Th e subclavian artery was exposed through a left infraclavicular incision along the level of the deltopectoral groove and was mobilized circumferentially. Th e brachial plexus was preserved. After heparin was administered, a side-biting Satinsky vascular clamp was applied to the subclavian artery, a 1-cm arteriotomy was created, and an 8-mm Gelsoft Plus graft (Sulzer Vascutek, Austin, TX) was sewn onto the artery in end-to-side fashion. Th e graft was tunneled subcutaneously down to the nipple level. A 21F arterial cannula was placed through the externalized graft and directed to within 1 cm of the anastomosis. Th e graft was secured to the cannula by tying umbilical tapes and to the skin by multiple silk sutures. Th e venous cannulation was achieved percutaneously under fl uoroscopic guidance using the Seldinger technique. A 22F QuickDraw venous cannula (Edwards Lifesciences, Irvine, CA) was secured to the skin with multiple sutures after being tunneled subcutaneously, as with the arterial cannula (Figure) .
Th e patient was extubated on day 1 after surgery, sat on a chair on day 2, and rode a stationary bicycle on day 4. His listing status remained the same, but no suitable donor was found for 9 days, during which he remained on ECMO. Th e 3.5 to Ambulatory extracorporeal membrane oxygenation with subclavian venoarterial cannulation to increase mobility and recovery in a patient awaiting cardiac transplantation Samuel Jacob, MD, Juan C. MacHannaford, MD, Themistokles Chamogeorgakis, MD, Gonzalo V. Gonzalez-Stawinski, MD, Joost Felius, PhD, Aldo E. Rafael, MD, Rajasekhar S. Malyala, MD, and Brian Lima, MD reduce complications and to increase fl ow to the upper body. Potential risks of this new subclavian technique include cannula dislodgement during ambulation or physical therapy, subclavian vein thrombosis, arterial "overcirculation"/edema to the upper extremity, requirement of imaging techniques for cannula placement, and arterial or venous injury from cannulation.
Patients on venoarterial ECMO support have traditionally been considered too unstable for active physical therapy, are frequently heavily sedated, and occasionally are on neuromuscular blocking agents. However, the ability to ambulate while on venoarterial ECMO has been facilitated by advances in extracorporeal technology and cannulation techniques (6) . Neuromuscular weakness and impairment in physical functioning are common sequelae of immobilization during critical illness. Active participation in physical and occupational therapy is not only considered safe and feasible, but is also the preferred approach to minimize debilitation in critically ill patients. Early rehabilitation is associated with improved rates of return to independent functioning, decreased rates of delirium, shorter durations of mechanical ventilation, and shorter length of stay in the intensive care unit and the hospital (7). Th us, subclavian venoarterial cannulation for ECMO may increase patient mobility and lead to quick recovery. Moreover, this methodology may enable longer durations of venoarterial ECMO support, potentially allowing patients to achieve multisystem recovery and a lower risk profi le for undergoing cardiac transplantation or LVAD implantation.
5.0 L/min fl ow was considered adequate with reversal of endorgan dysfunction and no evidence of metabolic acidosis. A more durable LVAD (HeartWare HVAD, Framingham, MA) was implanted with aortic valve replacement and concomitant ECMO decannulation. Th ere was no evidence of wound complications, infections related to the exposed graft, or limb complications, and recovery was unremarkable. On day 14, the patient received an automatic implantable cardioverter defi brillator and was discharged home the next day without complications. He is still awaiting a donor heart.
DISCUSSION
ECMO has become an essential tool in the care of patients with severe cardiac and pulmonary dysfunction who are refractory to conventional management. Th e technique has become more reliable due to improvements in equipment and increased experience (3) . Th e indications have been extended to more prolonged use in the intensive care unit, such as for bridge to transplant for both cardiac and lung transplantation and for support in cardiopulmonary replacement therapy in unstable patients (4, 5) . ECMO support can be deployed with multiple techniques, including peripheral or central cannulation. Both methods of cannulation carry risks of bleeding, while peripheral cannulation carries an added risk of limb ischemia (2) .
Th e most common route for peripheral cannulation in venoarterial ECMO involves the common femoral artery and vein (3). However, in addition to the risk of injury to the artery, blood fl ow to the heart and brain is mostly retrograde with direct cannulation of the femoral artery. Although we have adopted the former technique in our center, we shifted our practice toward subclavian venoarterial cannulation in order to 
